QID 357063

Date Published: 2024-02-01

QID 357063: Amazon Linux Security Advisory for runc : ALAS2DOCKER-2024-036

Aws is aware of( CVE-2024-21626, an issue affecting the runc component of several open source container management systems.
Under certain conditions, an actor could leverage a specially crafted container or container configuration to access files or directories outside the container's file system namespace. an updated version of runc that addresses the issue is available for amazon linux 1 (runc-1.1.11-1.0.amzn1), amazon linux 2 (runc-1.1.11-1.amzn2) and for amazon linux 2023 (runc-1.1.11-1.amzn2023).
Aws recommends that customers using runc or any container-related software apply those updates or a newer version. (
( CVE-2024-21626)



Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a securitybreach or could affect integrity, availability, and confidentiality.

  • CVSS V3 rated as Critical - 8.6 severity.
  • CVSS V2 rated as Medium - 5.4 severity.
    • Solution
    Please refer to Amazon advisory: ALAS2DOCKER-2024-036 for affected packages and patching details, or update with your package manager.
    Vendor References

    CVEs related to QID 357063

    CVE-2024-21626 |
    Software Advisories
    Advisory ID Software Component Link
    ALAS2DOCKER-2024-036 amazon linux 2 URL Logo alas.aws.amazon.com/AL2/ALASDOCKER-2024-036.html
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].